Metropolis Healthcare Limited (NSE: METROPOLIS), ISIN INE112L01020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
METROPOLIS last traded at ₹591.75 (+0.98%), with a 52-week range of ₹413.00 to ₹599.90 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 48.86%, FIIs 11.03%, DIIs 35.12%, mutual funds 32.67%.
EquiSense Score (ECS): 83/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.